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MRI-Guided Breast Biopsy
Student Researcher: Makayla Franko
Faculty Advisor: Dr. Elaine Halesey, Ed.D., R.T.(R)(QM)
Equipment for the Biopsy: 
• Breast Coil 
• Medial and lateral paddles for compression 
• Fiducial markers to identify the outer portion of the 
breast
• Sterile tray: two syringes with lidocaine, two 
syringes with lidocaine and epinephrine, gauze pads, 
scalpel, and grid  
• Localization device: small grid, introducer including 
plastic sheath with numeric grading, metallic stylist, 
and blunt tip plastic introducer, vacuum-assisted 
breast biopsy (VABB) apparatus and needle, and 
localization marker clip 
MRI-Guided Breast Biopsy Procedure:
• An IV is started. The patient is prone with breasts 
pendent in the coil. Compression is applied with grid 
fixed to the breast affected. The patient is imaged to 
relocate the lesion. 
• Axial T1-weighted 3D fat-saturated images are taken 
to relocate the lesion. Then the contrast is injected 
and post contrast dynamic T1 3D fat-saturated 
images are taken. The images are reviewed by the 
technologist and the radiologist to measure the 
location in the grid of the lesion. Once the lesion is 
located, the biopsy can be performed. 
• The radiologist confirms the lesion placement within 
the grid and numbs the breast. The localizer is 
placed in the breast and the patient is put back into 
the machine to confirm the localizer is in the region. 
• The biopsy begins and the VABB apparatus is 
inserted into the localizer. The radiologist will turn 
the VABB apparatus clockwise around the lesion 
collecting 10 samples from the breast. The VABB 
apparatus is removed, and a marker clip is placed in 
the breast to confirm the site of the biopsy on future 
imaging. 
• A final image is taken in the MRI to confirm clip 
placement. Then the patient receives a same day soft 
compression mammogram. 
Case Study: 
• This case study follows a 62-year-old women with 
known primary Non-Hodgkin's Lymphoma. 
• In November of 2016, the patient had an MRI of the 
breast that indicated a 13 mm lesion in her upper left 
breast. A needle biopsy revealed a proliferation of 
small atypical lymphocytes with a diffuse growth 
pattern and small eosinophils. 
• The patient was started on chemotherapy followed 
by radiotherapy treatments localized to the left 
breast. No significant uptake was found, and the 
patient was diagnosed in remission. 
• In 2018, a breast MRI demonstrated a non-mass 
enhancement measuring 33mm that was not 
demonstrated on ultrasound or mammography. 
• Since the lesion was only identified on MRI, an 
MRI-guided breast biopsy was scheduled. The 
biopsy was accessed with an 8-gauge VAB with 
lateral access to the breast in 30 minutes time. 
Twelve samples were taken. The results of her 
biopsy revealed the patient had ductal carcinoma in-
situ. Two-weeks later the patient underwent a lower 
external quadrantectomy of the breast on the lesion. 
The tumor was completely removed, and the patient 
was discharged in good health. 
Advantages and Disadvantages of  MRI-
Guided Breast Biopsy:
Advantages 
• The procedure requires the use of contrast media to 
enhance lesions resulting in better visualization and 
higher sensitivity than other modalities for imaging 
of the breast.
• “It has been shown that MR-guided vacuum-
assisted breast biopsies (VABB) are a fast, safe, and 
accurate method that cause only minimal scarring 
and no consecutive breast deformity compared to 
surgical breast biopsy” (Spick et. al., 2016, p. 3908)
Disadvantages
• The lesion may not enhance during the biopsy 
resulting in the study being canceled.
• The risk of rupture of implants.
• Cancer detection, false-negative, and 
underestimation rates vary among previously 
published studies using MR-guided vacuum-
assisted breast biopsy. (Spick et. al., 2016, p. 3908)
New Technology in MRI-Guided Breast 
Biopsy:
• MRI is always changing which requires equipment 
that evolves with it. Imaging sequences are being 
developed using diffusion-weighted imaging to 
eliminate the use of contrast media. Other 
researchers are developing an MR-compatible 
needle intervention robotic system that can 
approach tumors from the side with a bendable 
needle to allow better access. Other researchers are 
developing a coil to have the patient supine rather 
than prone on the MR table.
Conclusion: 
• MRI provides high visualization of breast lesions 
and is used along with mammography and 
ultrasound to detect and monitor lesions. If a lesion 
is only visualized on MRI, it would indicate the 
lesion needs be biopsied. MRI requires the use of the 
breast coil and biopsy equipment including a grid 
and VABB apparatus. The lesions are located by 
experienced breast radiologists and MR 
technologists. Once the lesion is targeted on quick 
prebiopsy breast scans, the biopsy is commenced. 
Following the biopsy, the patient receives a soft 
compression mammogram. The patient will also 
have follow-up imaging six months later. MRI gives 
patients superior imaging and allows for better 
visualization of lesions.
Introduction: 
• Magnetic Resonance Imaging (MRI) creates cross-
sectional images of the body. MRI does not use 
ionizing radiation. The images are created by 
magnetic fields and radiofrequencies reacting with 
biologic tissues. 
• “MRI is able to distinguish very small differences in 
contrast among tissues by manipulating biologic 
tissue with magnetic fields and radio waves.”  MRI’s 
ability to distinguish contrast between tissues makes 
it a top modality to image the breast. 
Breast MRI:
• Should be performed on days 3 through 14 of the 28-
day menstrual cycle. 
• The images are taken on 1.5T or 3T magnetic field 
strength machines. The patient is prone with breast 
pendent in the breast coil. 
• Contrast media is needed to enhance any lesions on 
the images. The most common sequences are T2 fat-
suppressed, pre-contrast T1 no-fat-suppressed, pre-
contrast T1 fat-suppressed, and post contrast T1 
images.
• All breast images are read using the breast imaging 
reporting and data system or BI-RADS.
Indications and Contraindications: 
Indications 
• Lesions found on imaging identified as BIRAD 3, 4, 
or 5 would indicate a breast biopsy.
Contradictions 
• Include claustrophobia, metallic implants that are 
not MRI safe, and individuals allergic to contrast 
media. Patients with deranged clotting function, 
anticoagulation, when the target lesion cannot be 
reidentified on pre biopsy images, and not being able 
to access the lesion.  
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Figure 1. Unenhanced T-2 weighted image (Papalouka et al., 2018, p. 908e23)
Figure 2. Components of MRI-compatible coaxial system (Gao et al., 2020, 
p.4676)
Figure 4. MRI-guided biopsy position (Gao et al., 2020, p. 4674)
Figure 3. Case study breast (Meucci et al., 2021, p. 929309-3)
